Zdravko Mitrovic
Zagreb, 10000, Croatia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Real-World Patterns and Outcomes of Anticoagulation Therapy in Pulmonary Embolism: An Observational Dual-Centre Registry Analysis.
Journal: Journal of cardiovascular development and disease
Published: August 23, 2025
A unique presentation of an osteolytic chronic lymphocytic leukemia/small lymphocytic lymphoma as a helmet-shaped tumor.
Journal: Surgical neurology international
Published: September 15, 2024
Long-Term Results of IFRT vs. ISRT in Infradiaphragmal Fields in Aggressive Non-Hodgkins's Lymphoma Patients-A Single Centre Experience.
Journal: Cancers
Published: October 12, 2023
Dose-adjusted EPOCH and rituximab (DA-EPOCH-R) in older patients with high-risk aggressive diffuse large B-cell lymphoma: A real-life multicenter study by the Croatian Cooperative Group for Hematologic diseases (KroHem).
Journal: European journal of haematology
Published: December 10, 2022
Efficacy and toxicity of infradiaphragmal radiotherapy fields in lymphoma patients: a single-centre experience.
Journal: La Radiologia medica
Published: November 09, 2022
Improvement in the outcomes of mantle cell lymphoma in the last decade: a real-life non interventional study of the Croatian Cooperative Group for Hematologic Diseases.
Journal: Croatian medical journal
Published: November 03, 2021
Psoas muscle index at the time of diagnosis might reflect the prognosis of classical Hodgkin's lymphoma patients.
Journal: Wiener klinische Wochenschrift
Published: February 06, 2021
Prolonged methylprednisolone premedication prior to obinutuzumab in patients with chronic lymphocytic leukemia.
Journal: Leukemia & lymphoma
Published: December 18, 2019
Bendamustine-based conditioning prior to autologous stem cell transplantation is associated with high rate of febrile neutropenia and higher mortality.
Journal: American journal of hematology
Published: October 26, 2018
Increased mean platelet volume (MPV) is an independent predictor of inferior survival in patients with primary and secondary myelofibrosis.
Journal: International journal of hematology
Published: July 31, 2017
Last Updated: 09/26/2026